Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,665 Cr₹1,817 Cr₹1,669 Cr₹1,541 Cr₹1,242 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,665 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,665 Cr
Mar2024₹1,817 Cr
Mar2023₹1,669 Cr
Mar2022₹1,541 Cr
Mar2021₹1,242 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2025 ₹1,665 Cr
-8.38
Mar2024 ₹1,817 Cr
8.91
Mar2023 ₹1,669 Cr
8.30
Mar2022 ₹1,541 Cr
24.10
Mar2021 ₹1,242 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,276.6 Cr -4.9% 6.6% -22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-4.9%

6.6%

-22.9%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses